Reaction

Fungal Sepsis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 827 reports · 52 co-occurring drugs

As of the last recalculation, Fungal Sepsis appears in 827 FAERS reports alongside 52 co-occurring drug terms. The strongest observed disproportionality signal is GANCICLOVIR (PRR 79.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ganciclovir3179.279.4
Ganciclovir Sodium3279.179.4
Amphotericin B3266.867.0
Micafungin Sodium1545.345.4
Meropenem5344.344.4
Heparin Sodium2139.439.5
Thiotepa1437.537.6
Fludarabine Phosphate5235.435.5
Busulfan1829.429.4
Itraconazole1328.428.5
Cytarabine6027.027.0
Anti-Thymocyte Globulin (Rabbit)825.225.2
Voriconazole Injection2124.925.0
Daptomycin924.824.8
Basiliximab1123.823.9
Norepinephrine1023.823.8
Fluconazole6123.623.6
Sirolimus1222.722.8
Vincristine Sulfate2522.122.1
Mesna Injection721.521.5
Voriconazole2521.321.3
Mesna721.121.1
Posaconazole Delayed-Release920.820.9
Piperacillin Sodium,Tazobactam Sodium2120.420.4
Vancomycin Hydrochloride5020.320.3
Magnesium Sulfate In Water For1019.920.0
Piperacillin And Tazobactam1019.919.9
Vancomycin4319.719.7
Magnesium Sulfate Heptahydrate1019.519.6
Magnesium Sulfate1019.519.5
Norepinephrine Bitartrate1119.519.5
Dapagliflozin2318.918.9
Posaconazole1218.818.9
Miconazole Nitrate617.417.4
Tacrolimus9617.317.3
Mycophenilic Acid1417.317.3
Etoposide4616.616.6
Pegaspargase816.616.6
Tacrolimus Ointment 0.1%7416.316.3
Tacrolimus Extended-Release Capsules7416.316.3
Cefepime916.016.0
Cefepime Hydrochloride1015.815.8
Lopinavir And Ritonavir815.015.0
Amikacin1014.914.9
Entecavir613.013.0
Azacitidine For912.612.6
Azacitidine1412.112.1
Doxorubicin Hydrochloride1511.811.8
Venetoclax2711.411.4
Rocuronium Bromide510.710.7
Blinatumomab49.79.7
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride75.75.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.